NDC 59676-580

Janssen COVID-19 Vaccine

Ad26.cov2.s

Janssen COVID-19 Vaccine is a Intramuscular Injection, Suspension in the Vaccine category. It is labeled and distributed by Janssen Products, Lp. The primary component is Ad26.cov2.s.

Product ID59676-580_00519468-8107-11eb-80da-f7ddfb2ca371
NDC59676-580
Product TypeVaccine
Proprietary NameJanssen COVID-19 Vaccine
Generic NameAd26.cov2.s
Dosage FormInjection, Suspension
Route of AdministrationINTRAMUSCULAR
Marketing Start Date2021-01-04
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameJanssen Products, LP
Substance NameAD26.COV2.S
Active Ingredient Strength2147483647 {VP}/.5mL
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 59676-580-15

10 VIAL, MULTI-DOSE in 1 CARTON (59676-580-15) > 2.5 mL in 1 VIAL, MULTI-DOSE (59676-580-05)
Marketing Start Date2021-01-04
NDC Exclude FlagN
Sample Package?N

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.